Covid-19 vaccine makers slump on expected patent waiver

Photo: EPA

The stocks of all companies involved in production of Covid-19 vaccines fell, as US and EU backed the call from the World Health Organisation to waive patent rights claims over the jabs production, Reuters reported. The share slumps came even as some analysts raised doubts about any near-term pressure on Covid-19 vaccine sales from discussions of waiving intellectual property rights, given the manufacturing complexity and scarcity of raw materials. Combined, Pfizer and Moderna have forecast a total of over $45 billion in sales this year for their Covid-19 vaccines.

Among companies with Covid-19 vaccines, shares of Pfizer fell 1.7% and were among the biggest weights on the benchmark S&P 500 index, while US shares of its German partner BioNTech SE shed 0.6% in mid-week deals after falling as much as 15% overall.

Moderna was off 1.3%, recovering after being down nearly 12%, while Johnson & Johnson and AstraZeneca were little changed, as the broad S&P 500 rose 0.2%. "This measure is a potential risk to the long-term tail for the vaccine players – though we remind investors that the Street and share prices were already skeptical on the longer-term sustainability of these businesses," Barclays analysts said in a note.

Shares of other US companies developing Covid-19 vaccines were also shaken. Novavax, whose vaccine has yet to be authorized by any country but is gearing up for deliveries later this year, fell nearly 10% initially but were up 1.6% in afternoon trade. Germany's Curevac which has sought approval for its Covid-19 vaccine, plunged by 18%. Shares of China's CanSino Biologics, which makes a single-dose Covid-19 vaccine, were off 15%.

Similar articles

  • Emirates sinks in $5.5 bn pandemic loss

    Emirates sinks in $5.5 bn pandemic loss

    The Dubai based carrier Emirates will receive another multi-billion dollars injection which may ease its way out of the pandemic downturn, Reuters reported. The Covid-19 related restrictions have deteriorated the business of the airline company. Emirates pocketed another $1.1 billion in state support funds from Dubai as demand for long-haul travel slumped due to the coronavirus threat. Emirates posted first full-year loss in over three decades.

  • Hyundai, GM eye lucrative flying cars market

    Hyundai, GM eye lucrative flying cars market

    The flying cars will become shortly part of regular traffic with major producers pushing hard to overcome competition in research and development, Reuters reported. Hyundai and General Motors both unveiled advanced plans with the Hyundai project expected to be introduced in air-taxi service by 2025. GM admitted it could take until 2030 to introduce flying cars as air-taxis for commercial usage by 2030.